Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RMD Stock Annual Income Statement. Download in Excel

ResMed Inc. logo

ResMed Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

237.27
 
USD
  
5.69
  
(2.46%)
Previous close: 231.58  Open: 231.0  Bid: 232.0  Ask: 233.5
52 week range    
164.12   
   260.49
Mkt Cap: 35,616 M  Avg Vol (90 Days): 948,174
Peers   
TMO / 
MDT / 
ELMD / 
MASI / 
AHPI / 
INGN / 
Last updated: Sunday 22nd December 2024

Stock Rankings

56
MarketXLS Rank
70
Value
46
Technical
52
Quality
How are these ranks calculated?
Search for a stock

Financials

RMD Income Statement

Annual
Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22Jun-23Jun-24
AcquisitionExpense5 M10 M6 M2 M11 M
Amortization of intangibles264 M1,059 M1,065 M1,069 M43 M50 M45 M40 M30 M33 M
Basic EPS from continuing operations2.512.512.422.212.834.313.275.346.126.94
Basic EPS total2.512.512.422.212.834.313.275.346.126.94
Basic weighted shares outstanding140 M140 M141 M143 M143 M144 M145 M146 M147 M147 M
Cost of sales668 M772 M865 M978 M1,113 M1,239 M1,358 M1,514 M1,837 M1,997 M
Depreciation151 M155 M157 M160 M165 M177 M
Depreciation unreconciled43 M50 M45 M40 M30 M33 M
DepreciationAndAmortization43 M50 M45 M40 M30 M33 M
Diluted EPS total2.472.492.42.192.84.273.245.36.096.92
Diluted normalized net income/share2.472.492.42.192.84.273.245.36.096.92
Diluted weighted shares outstanding143 M142 M142 M144 M144 M146 M146 M147 M147 M148 M
Dividends paid per share1.121.21.321.41.481.561.561.681.761.92
Earnings from equity interest-157 M-168 M-186 M-199 M-16 M-25 M-11 M-8 M-7 M-2 M
EarningsFromEquityInterestNetOfTax-157 M-168 M-186 M-199 M-16 M-25 M-11 M-8 M-7 M-2 M
GainOnSaleOfSecurity15 M-12 M10 M-4 M
GeneralAndAdministrativeExpense479 M488 M554 M600 M645 M677 M670 M738 M874 M917 M
Gross operating profit1,011 M1,066 M1,202 M1,362 M1,494 M1,718 M1,839 M2,024 M2,356 M2,655 M
Income before tax436 M440 M419 M521 M519 M733 M884 M960 M1,102 M1,265 M
Income restructuring and M&A-348 M7 M12 M18 M9 M9 M-11 M64 M
Income taxes83 M87 M76 M206 M114 M111 M409 M181 M204 M244 M
Interest income26 M17 M17 M16 M2 M1 M362000.0-47 M-46 M
InterestExpenseNonOperating6 M11 M28 M28 M36 M40 M24 M22 M47 M
LossAndLossAdjustmentExpectedIncurred7 M8 M2 M600000.0800000.0
MiscOtherSpecialCharges6 M5 M4 M-9 M-11 M-12 M301000.03 M-6 M-3 M
Net income from total operations353 M352 M342 M316 M405 M622 M475 M779 M898 M1,021 M
NetIncomeCommonStockholders370 M400 M435 M408 M482 M622 M475 M779 M898 M1,021 M
NetIncomeContinuousOperations353 M352 M342 M316 M405 M622 M475 M779 M898 M1,021 M
NetNonOperatingInterestIncomeExpense20 M6 M-11 M-12 M-34 M-39 M-24 M-22 M-47 M-46 M
NonRecurringOperationExpense9 M41 M-600000.0
Normalized income-1,845 M292 M315 M442 M482 M564 M707 M1,321 M
Operating income409 M429 M426 M542 M579 M810 M904 M1,000 M1,132 M1,320 M
Operating income before depreciation (EBITDA)515 M538 M559 M670 M706 M990 M1,104 M1,177 M1,299 M1,481 M
OperatingExpense602 M638 M776 M820 M915 M908 M935 M1,022 M1,224 M1,335 M
Other income net-6 M-5 M-4 M9 M27 M37 M-4 M-19 M3 M9 M
OtherGandA479 M488 M554 M600 M645 M677 M670 M738 M874 M917 M
OtherImpairmentOfCapitalAssets3 M2 M12 M15 M-15 M-15 M3 M5 M5 M
OtherOperatingExpenses-9 M-24 M-47 M-46 M-39 M-30 M-31 M35 M34 M41 M
RentAndLandingFees17 M17 M20 M21 M23 M
Research & development expense115 M119 M144 M155 M181 M202 M225 M254 M288 M308 M
ResearchExpense115 M119 M144 M155 M181 M202 M225 M254 M288 M308 M
RestructringAndMnAIncome-348 M7 M12 M18 M9 M9 M-11 M64 M
Revenue per share264 M1,059 M1,065 M1,069 M43 M50 M45 M40 M30 M33 M
SalariesAndWages-14 M-25 M-20 M-17 M-27 M-40 M-23 M-29 M-25 M-15 M
Selling Gen & administrative expense479 M488 M554 M600 M645 M677 M670 M738 M874 M917 M
Special income/charges348 M-7 M-21 M-18 M-51 M600000.0-9 M11 M-64 M
Total Income available for interest expense (EBIT)442 M451 M447 M550 M555 M809 M912 M983 M1,102 M1,265 M
Total common shares outstanding141 M141 M142 M143 M144 M145 M145681.0146 M147 M147 M
Total net income353 M352 M342 M316 M405 M622 M475 M779 M898 M1,021 M
Total ordinary shares147 M147 M147 M147 M147 M147 M147 M147 M147 M147 M
Total revenues1,679 M1,839 M2,067 M2,340 M2,607 M2,957 M3,197 M3,578 M4,223 M4,685 M
TotalExpenses1,270 M1,410 M1,641 M1,798 M2,027 M2,147 M2,293 M2,536 M3,061 M3,332 M
TotalRevenue1,679 M1,839 M2,067 M2,340 M2,607 M2,957 M3,197 M3,578 M4,223 M4,685 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University